AlphaMadera's AlphaVal page classifies Bowhead Specialty Holdings Inc. as a Banks, Insurers & Asset Managers business and values it using P/Tangible Book × ROE Quality, then compares the result to the current market price to flag BOW as undervalued, fairly valued, or overvalued.

What is Bowhead Specialty Holdings Inc.'s fair value?

Fair value for BOW comes from a P/Tangible Book × ROE Quality model -- the approach AlphaVal selected for this company's Banks, Insurers & Asset Managers classification. The live AlphaVal page shows bear, base, and bull scenarios alongside the key assumption behind each.

How does AlphaMadera value BOW?

AlphaVal routes each company to one of ten valuation archetypes based on its business model. BOW was classified as Banks, Insurers & Asset Managers and is valued using P/Tangible Book × ROE Quality, built from BOW's most recent reported fundamentals.

BOW - Bowhead Specialty Holdings Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $32.80 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Moderate

Trading 33.4% below fair value

Current Price $33.60

Bear Case $36.21 7.8% upside ($36.21 - $33.60) / $33.60 = 7.8% ROTCE 9.7% → 2.87x TBV

Fair Value $50.43 50.1% upside ($50.43 - $33.60) / $33.60 = 50.1% ROTCE 13.0% → 4.00x TBV

Bull Case $50.43 50.1% upside ($50.43 - $33.60) / $33.60 = 50.1% ROTCE 14.9% → 4.00x TBV

Adjust Assumptions

Return on Tangible Equity

13.0%

Cost of Equity

6.0%

Key Value Driver

ROTCE (13.0%) vs. cost of equity (6.0%)

Terminal Value % of EV

Implied Market Multiple 2.67x

Market is pricing in (growth)

Plain-Language Summary

With ROTCE of 13.0% vs. 6.0% cost of equity, fair P/TBV is 4.00x on $12.61 tangible book, implying $50.43 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (7 analysts) $32.80

Analyst Range $28.00 – $34.00

Divergence from AlphaVal 54%

Warnings

⚠ Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.

⚠ Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.

ℹ Wall Street's average price target is $32.80 (from 7 analysts). Our estimate is 54% above the consensus -- consider that gap carefully.

Key Risks

Book value quality matters as much as level — check loan loss reserves
Interest rate sensitivity creates non-linear earnings surprises
Insurance reserving is actuarial, not financial — errors emerge slowly